PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products & services throughout the pharmaceutical R&D process and commercial production. Its core businesses include: a rationally designed building blocks (BBs) collection, supplying from discovery, to development & commercial; development & manufacturing of RSMs, intermediates & APIs for drug development & commercial. Officially operated in 2008, PharmaBlock has rapidly gained recognition for its outstanding capabilities in the design, synthesis, & supply of novel BBs. It has generated a large and unique collection of high-quality and diverse BBs, which are increasingly adopted by drug hunters to enrich the structure options, improve compound quality, expand patent space and eventually accelerate drug discovery projects. Inspired by the BBs, it has established a powerful drug discovery platform for medicinal chemists to quickly identify hit/lead. The platform includes a set of efficient tools, including but not limited to FBDD, DELT, & Virtual Screening. Following the new molecules advancing from discovery to development, and into the market, the company is committed to a more comprehensive & long-term service to valued customers. In addition to strengthening process R&D capabilities & mfg. capacity to secure the sustainable supply of BBs, the company is providing CDMO solutions of RSMs, key intermediates & APIs. To further realize safe, efficient and green process & mfg., it has developed an advanced chemistry & engineering technology platform, featuring flow chemistry, micropacked bed hydrogenation, catalysis, crystallization, solid state chemistry etc. Over the past years, PharmaBlock has partnered with almost all the top pharmaceutical companies, and hundreds of small to medium-sized biotechs around the world. Our ever changing mission is to support clients to accelerate drug discovery & development, and move the new molecule to commercial in full speed.
View Top Employees from PharmaBlock GroupWebsite | http://www.pharmablock.com |
Revenue | $187.1 million |
Employees | 180 (89 on RocketReach) |
Founded | 2006 |
Address | Xuefu Roadnanjing hi-Tech Zone 10, Nanjing, Jiangsu, CN |
Phone | +86 400 025 5188 |
Fax | (408) 550-1891 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Other Commercial Services, Building blocks, Healthcare, Custom synthesis, Process development, Manufacturing of key intermediates and APIs |
Web Rank | 4 Million |
Keywords | Drug Development And Manufacturing, Pharmaceutical Intermediates, Active Pharmaceutical Ingredients, Research Chemicals |
Competitors | Accelerate Diagnostics, Inc., Bachem, Bayer Schering Pharma, Fitch Learning, Sai Life Sciences Ltd |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular PharmaBlock Group employee's phone or email?
The PharmaBlock Group annual revenue was $187.1 million in 2024.
Minmin Yang is the Chairman of PharmaBlock Group.
89 people are employed at PharmaBlock Group.
PharmaBlock Group is based in Nanjing, Jiangsu.
The NAICS codes for PharmaBlock Group are [32541, 3254, 32, 325].
The SIC codes for PharmaBlock Group are [283, 28].